Abstract
Moving Beyond Directly Observed Therapy for Tuberculosis.
Highlights
Mycobacterium tuberculosis often develops resistance in the setting of monotherapy, either de facto or actual (historically, or in the setting of extensively drug resistant tuberculosis (XDR-TB) salvage regimens) [1,2,3,4]
This week in PLOS Medicine, Fielding and colleagues present a cluster randomized trial of an alternative strategy—managing adherence with reminders delivered by an electronic pillbox or text messaging
To what degree does nonadherence lead to treatment failure or acquisition of drug resistance? In contrast to HIV, for which the complex relationship between adherence, pharmacokinetics, and resistance for each antiretroviral class is defined [13], the levels and patterns of adherence that lead to TB treatment failure and drug resistance remain largely unknown [14]
Summary
To what degree does nonadherence lead to treatment failure or acquisition of drug resistance? In contrast to HIV, for which the complex relationship between adherence, pharmacokinetics, and resistance for each antiretroviral class is defined [13], the levels and patterns of adherence that lead to TB treatment failure and drug resistance remain largely unknown [14]. This week in PLOS Medicine, Fielding and colleagues present a cluster randomized trial of an alternative strategy—managing adherence with reminders delivered by an electronic pillbox or text messaging.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.